Last 44.80
Change Today -1.50 / -3.24%
Volume 203.0K
MDGS On Other Exchanges
Symbol
Exchange
Tel Aviv
As of 10:24 AM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

medigus ltd (MDGS) Snapshot

Open
$45.20
Previous Close
$46.30
Day High
$46.40
Day Low
$44.30
52 Week High
10/2/13 - $83.00
52 Week Low
08/21/14 - $43.00
Market Cap
112.0M
Average Volume 10 Days
109.9K
EPS TTM
$-0.07
Shares Outstanding
249.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIGUS LTD (MDGS)

Related News

No related news articles were found.

medigus ltd (MDGS) Related Businessweek News

No Related Businessweek News Found

medigus ltd (MDGS) Details

Medigus Ltd., a medical device company, designs, develops, and sells endoscopic procedures and devices. The company offers Medigus Ultrasonic Surgical Endostapler system, an endoscope device comprising a surgical stapler, miniature camera, and an ultrasound sensor for incisionless treatment of gastroesophageal reflux disease. Medigus Ltd. was founded in 2000 and is headquartered in Omer, Israel.

Founded in 2000

medigus ltd (MDGS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medigus ltd (MDGS) Key Developments

NASA Selects Medigus' micro ScoutCam(TM) 1.2 For Robotic Refueling Mission Demonstration

Medigus Ltd. announced that the National Aeronautics and Space Administration (NASA) has incorporated Medigus' micro ScoutCam(TM) 1.2, into its Visual Inspection Poseable Invertebrate Robot (VIPIR) tool. VIPIR is a robotic, maneuverable, borescope inspection tool that is being tested as part of the Robotic Refueling Mission, an experiment on the International Space Station that has been demonstrating tools, technologies and techniques for on-orbit satellite servicing since 2011. micro ScoutCam(TM) 1.2 is being utilized as the borescope camera on VIPIR, a tool designed to provide unique visual inspection capabilities in space. The use of micro ScoutCam(TM) 1.2 fits under the previously established contract with NASA.

MediGus Ltd. Establishes Camera Division; Appoints Yaron Silberman as VP Sales & Marketing for Camera Division

Medigus Ltd. announced the establishment of its camera division to support strategic expansion and growth of its revolutionary micro camera business. Following Medigus' innovative trans-oral surgical system for the incisionless treatment of GERD, this expansion will fully utilize the company's technological capabilities with a dedicated team to drive it forward. The Medigus camera division's lead product is micro ScoutCam(TM) 1.2, a revolutionary and proprietary 1.2mm diameter waterproof CMOS video camera that can be used in extreme environments and is the smallest such camera in the world. micro ScoutCam(TM) 1.2 can reach places where existing cameras cannot. With capabilities ranging from going into a vessel or a coronary stent to a refueling mission in space, it opens up new possibilities across medical and industrial applications for Medigus and its partners looking to incorporate the latest advancement in visual technology. The Medigus camera division will be led by Yaron Silberman, PhD, VP Sales & Marketing, who has an extensive and well-rounded background in the high-tech medical device industry. In this role, he will lead the strategy and business development of the Medigus micro camera business.

Medigus Ltd. Announces Executive Changes; Establishes Subsidiary Office in San Francisco, California Bay Area

Medigus Ltd. announced key appointments to its global commercial team. Key appointments include: Tom Dempsey, new VP/GM United States, brings a diverse functional experience, including 19 years leading start-ups through established medical device companies including Boston Scientific and Endogastric Solutions (EGS), where he was VP, Commercialization. Mr. Dempsey was previously CEO of Medical Diagnostic Technologies and Peak Heart; Sheila Stevens, PhD, Sr. Director Regulatory and Clinical, has an extensive track record within Clinical and Regulatory Affairs including positions at Clear Catheter Systems, BaroSense Inc., Apneon, and Kyphon; Lori Saper, Sr. Director Professional Education, has vast experience working as an educator in the Operating Room (OR) and ICU environment with surgical and clinical teams. Ms. Saper brings over 20 years of experience in Medical and Clinical Trial Management in Europe and the U.S including positions at BioVentryx, Pioneer Surgical Technology, and Kyphon; Milena Ridl, new VP Europe, brings strong commercial and market development experience throughout Europe, including leadership roles at Kyphon, MiMedx and SpineAlign. These new team members join the company's established operating and R&D team based in Omer, Israel. The company also announced that it has established a subsidiary office in the San Francisco, California Bay Area to drive regional adoption for MUSE in the U.S.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDGS:IT 44.80 -1.50

MDGS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDGS.
View Industry Companies
 

Industry Analysis

MDGS

Industry Average

Valuation MDGS Industry Range
No financial data is available for MDGS.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIGUS LTD, please visit www.medigus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.